A paper of mine (from an extremely old project) final came out in final form today. Here are some details.
Title: Counterparty Credit Limits: The Impact of a Risk-Mitigation Measure on Everyday Trading
Authors: Martin D. Gould, Nikolaus Hautsch, Sam D. Howison, and Mason A. Porter
Abstract: A counterparty credit limit (CCL) is a limit that is imposed by a financial institution to cap its maximum possible exposure to a specified counterparty. CCLs help institutions to mitigate counterparty credit risk via selective diversification of their exposures. In this paper, we analyse how CCLs impact the prices that institutions pay for their trades during everyday trading. We study a high-quality data set from a large electronic trading platform in the foreign exchange spot market that allows institutions to apply CCLs. We find empirically that CCLs had little impact on the vast majority of trades in this data set. We also study the impact of CCLs using a new model of trading. By simulating
our model with different underlying CCL networks, we highlight that CCLs can have a major impact in some situations.
ReplyDeleteI was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
liver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.